These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 2527976)

  • 1. Effect of intravenous immune globulin on the coagulopathy of Kawasaki syndrome.
    Glode MP; Joffe LS; Wiggins J; Clarke SH; Hathaway WE
    J Pediatr; 1989 Sep; 115(3):469-73. PubMed ID: 2527976
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Coagulopathy and platelet activation in Kawasaki syndrome: identification of patients at high risk for development of coronary artery aneurysms.
    Burns JC; Glode MP; Clarke SH; Wiggins J; Hathaway WE
    J Pediatr; 1984 Aug; 105(2):206-11. PubMed ID: 6235335
    [TBL] [Abstract][Full Text] [Related]  

  • 3. High-dose intravenous gamma-globulin therapy in Kawasaki disease.
    Hwang BT; Lin CY; Hsieh KS; Tsuei DH; Meng CC
    Zhonghua Min Guo Xiao Er Ke Yi Xue Hui Za Zhi; 1989; 30(1):15-22. PubMed ID: 2484055
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Left ventricular contractility and function in Kawasaki syndrome. Effect of intravenous gamma-globulin.
    Newburger JW; Sanders SP; Burns JC; Parness IA; Beiser AS; Colan SD
    Circulation; 1989 Jun; 79(6):1237-46. PubMed ID: 2720925
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The treatment of Kawasaki syndrome with intravenous gamma globulin.
    Newburger JW; Takahashi M; Burns JC; Beiser AS; Chung KJ; Duffy CE; Glode MP; Mason WH; Reddy V; Sanders SP
    N Engl J Med; 1986 Aug; 315(6):341-7. PubMed ID: 2426590
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treatment of Kawasaki disease.
    Nakashima L; Edwards DL
    Clin Pharm; 1990 Oct; 9(10):755-62. PubMed ID: 2242655
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prevention of giant coronary artery aneurysms in Kawasaki disease by intravenous gamma globulin therapy.
    Rowley AH; Duffy CE; Shulman ST
    J Pediatr; 1988 Aug; 113(2):290-4. PubMed ID: 2456378
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical trial of single-dose intravenous gamma globulin in acute Kawasaki disease. Preliminary report.
    Engle MA; Fatica NS; Bussel JB; O'Loughlin JE; Snyder MS; Lesser ML
    Am J Dis Child; 1989 Nov; 143(11):1300-4. PubMed ID: 2479260
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A single intravenous infusion of gamma globulin as compared with four infusions in the treatment of acute Kawasaki syndrome.
    Newburger JW; Takahashi M; Beiser AS; Burns JC; Bastian J; Chung KJ; Colan SD; Duffy CE; Fulton DR; Glode MP
    N Engl J Med; 1991 Jun; 324(23):1633-9. PubMed ID: 1709446
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immune hemolysis, disseminated intravascular coagulation, and serum sickness after large doses of immune globulin given intravenously for Kawasaki disease.
    Comenzo RL; Malachowski ME; Meissner HC; Fulton DR; Berkman EM
    J Pediatr; 1992 Jun; 120(6):926-8. PubMed ID: 1593353
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Infliximab for intensification of primary therapy for Kawasaki disease: a phase 3 randomised, double-blind, placebo-controlled trial.
    Tremoulet AH; Jain S; Jaggi P; Jimenez-Fernandez S; Pancheri JM; Sun X; Kanegaye JT; Kovalchin JP; Printz BF; Ramilo O; Burns JC
    Lancet; 2014 May; 383(9930):1731-8. PubMed ID: 24572997
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Study on coronary artery lesions in patients with Kawasaki disease: recent 9 years' experience].
    Wu JR; Hwang KP; Tu JG; Dai ZK; Huang TY
    Gaoxiong Yi Xue Ke Xue Za Zhi; 1993 Jan; 9(1):27-38. PubMed ID: 7682261
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of initial corticosteroid therapy on coronary artery aneurysm formation in Kawasaki disease: a meta-analysis of 862 children.
    Wooditch AC; Aronoff SC
    Pediatrics; 2005 Oct; 116(4):989-95. PubMed ID: 16199713
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Treatment of Kawasaki syndrome: a comparison of two dosage regimens of intravenously administered immune globulin.
    Barron KS; Murphy DJ; Silverman ED; Ruttenberg HD; Wright GB; Franklin W; Goldberg SJ; Higashino SM; Cox DG; Lee M
    J Pediatr; 1990 Oct; 117(4):638-44. PubMed ID: 2213395
    [TBL] [Abstract][Full Text] [Related]  

  • 15. High-Dose Aspirin is Associated with Anemia and Does Not Confer Benefit to Disease Outcomes in Kawasaki Disease.
    Kuo HC; Lo MH; Hsieh KS; Guo MM; Huang YH
    PLoS One; 2015; 10(12):e0144603. PubMed ID: 26658843
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunomodulation by intravenous immune globulin in Kawasaki disease.
    Leung DY
    J Allergy Clin Immunol; 1989 Oct; 84(4 Pt 2):588-93; discussion 593-4. PubMed ID: 2677095
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical aspects of 100 patients with Kawasaki disease.
    Tizard EJ; Suzuki A; Levin M; Dillon MJ
    Arch Dis Child; 1991 Feb; 66(2):185-8. PubMed ID: 1900405
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intravenous gamma globulin therapy in Kawasaki disease--trial of low dose gamma globulin.
    Okuni M; Harada K; Yamaguchi H; Yanagawa H; Sonobe T; Kawasaki T
    Prog Clin Biol Res; 1987; 250():433-9. PubMed ID: 3321083
    [No Abstract]   [Full Text] [Related]  

  • 19. Economic evaluation of intravenous immune globulin therapy for Kawasaki syndrome.
    Klassen TP; Rowe PC; Gafni A
    J Pediatr; 1993 Apr; 122(4):538-42. PubMed ID: 8463897
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Kawasaki's disease in northern Italy: a multicenter retrospective study of 250 patients.
    Falcini F; Cimaz R; Calabri GB; Picco P; Martini G; Marazzi MG; Simonini G; Zulian F
    Clin Exp Rheumatol; 2002; 20(3):421-6. PubMed ID: 12102484
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.